BCAX
#2302
Bicara Therapeutics Inc. - Common Stock
17.2 6 USD
+0.05%
Market Price
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
Jahresspanne
Tagesänderung
+5.12%
Monatliche Änderung
-25.95%
6 month change
-21.55%
Jahresänderung
+19.53%
Vorheriger Schlusskurs
16.4 2
Open
16.3 2
Tief
15.8 5
Hoch
17.3 3
Financials
2026
Current report, 21 Aug 2026
Bicara Therapeutics Inc. current report, 21 August 2026
8-K
Current report, Q3 FY2026
Bicara Therapeutics Inc. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
Bicara Therapeutics Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
Bicara Therapeutics Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
Bicara Therapeutics Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Bicara Therapeutics Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Bicara Therapeutics Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
Bicara Therapeutics Inc. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
Bicara Therapeutics Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
Bicara Therapeutics Inc. current report, Q1 FY2026
8-K